August 6th 2025
Can AI compete with the well-oiled machine of the contemporary clinic?
PAUL implant: Good IOP lowering, fewer complications compared with Baerveldt device
October 3rd 2023Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications
Study: MERCURY-3 trial results support efficacy of Roclanda
September 13th 2023MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.
SOE 2023: What new surgeries will hit the glaucoma market?
June 17th 2023Ophthalmology Times Europe© is proud to cover the European Society of Ophthalmology 2023. We spoke to SOE presenter Panayiota Founti, PhD, FEBO, Consultant Ophthalmic Surgeon & Training Director, Glaucoma Service Moorfields Eye Hospital, London, UK.
Glaucoma 360: Eyedrop targets and reduces episcleral venous pressure in glaucoma
February 8th 2023Thurein Htoo, MS, MBA, CEO and co-founder of Qlaris Bio, took the podium at the New Horizons Forum at the Glaucoma 360 conference in San Francisco to discuss the performance of the company’s episcleral venous pressure eyedrop, QLS-111.